SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-000716
Filing Date
2023-01-12
Accepted
2023-01-12 16:10:07
Documents
13
Period of Report
2023-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flgt-20230106.htm   iXBRL 8-K 56766
2 EX-1.1 flgt-ex1_1.htm EX-1.1 14550
  Complete submission text file 0000950170-23-000716.txt   187786

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgt-20230106_pre.xml EX-101.PRE 10506
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgt-20230106_lab.xml EX-101.LAB 12798
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgt-20230106.xsd EX-101.SCH 2482
7 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20230106_htm.xml XML 4530
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 23526031
SIC: 8071 Services-Medical Laboratories